Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
Key points for self-injection: rotate injection sites to prevent lipodystrophy, inject subcutaneously (not intramuscularly), and allow the medication to warm slightly toward room temperature for 15-30 minutes before injecting if it has been refrigerated
Hayashi K, et al
FDA has approved Foundayo (orforglipron), developed by Eli Lilly and Company, as the first oral non-peptide GLP-1 receptor agonist for chronic weight management
Product Disclaimer: Research Purposes Only This product is intended strictly for laboratory research and in vitro analysis
US$ 20.43
US$ 29.26
US$ 29.26
US$ 28.02
US$ 23.68
US$ 24.31
US$ 23.05
US$ 28.34
US$ 26.70
US$ 21.69
